YuMengge

PhD, MBBS, MMed (Paediatrics), Research Fellow in Ong Sin Tiong lab @DukeNUS, Singapore

[Duke-NUS Medical School @dukenus]

#DukeNUS scientists and collaborators investigated how an inherited genetic variation in East Asians leads to drug resistance and aggressive cancer growth: https://t.co/QNVkRRCBTL

📸: Duke-NUS Medical School

#Research #Leukaemia #Cancer

[YuMengge @yu_mengge]

Excited to share our latest publication!!!🧬🐁Our findings reveal BDP’s key role in leukemia initiation and treatment response. Huge thanks to our collaborators at @jacksonlab and Dr. Charles Chuah from SGH! Read more here: https://t.co/2juy8vn193

[Itai Yanai @ItaiYanai]

Doing good science is 90% finding a science buddy to constantly talk to about the project.

[Rizwan Romee @romeerizwan]

Excited to share our paper in @NatureBiotech, work led by Shaobo Yang and @MichalSheffer in my lab in collaboration with @JiaheLi276994 @UMich
https://t.co/xLGA7JjpBX #NK #immunotherapy #bacteria @DanaFarberNews @DanaFarber #RomeeLab

[International CML Foundation @icmlf]

🚨 Reminder! Don’t miss the iCMLf Conversation on Oct 8th for key takeaways from #ESHCML2024

🗓️ Oct 8, 2024
⏰ 13:00 CEST

Prof. Jorge Cortes & Prof. Daniela Krause will share the latest insights.

🔗 Join here: https://t.co/3imz6ucnOS

[ESH (Haematology) @ESHaematology]

Exciting data about CD26+CD35+ progenitor cells from Ram K. Thakur, a discussion from
@yu_mengge exploring the role of NK immune cells and @shaundavid01 with an exploration into the composition of BM immune cells to predict TFR.#ESHCML2024 #ESHCONFERENCES #CMLsm
@icmlf

[International CML Foundation @icmlf]

Our March Papers of the Month, curated by Professor Tim Hughes, are now available. View the full list of papers via our website: https://t.co/TCRTjMlnWc 💬🔍

#CML #Chronicmyeloidleukemia #iCMLf #CMLResearch

[Duke-NUS Medical School @dukenus]

Although Assoc Prof Ong Sin Tiong has switched his focus to research, his commitment to helping patients with life-threatening diseases remains.

Read his inspiring story: https://t.co/kt6Esrc1HF

#DukeNUSResearch #medicine #cancer #clinicianscientist

[International CML Foundation @icmlf]

Discussions at EHA2023 included enhancing TFR eligibility/success & exploring therapeutic potential of allosteric BCR::ABL1 inhibitors. Prof. Hochhaus & Prof. S. Tiong Ong share highlights from the congress in our upcoming iCMLf Conversation. Register: https://t.co/f5OhcIR5KD

[Vaidehikrishnan @Vaidehikrishna4]

We are very happy to share our latest #singlecell study on identifying the features of primary tyrosine kinase inhibitor (TKI) resistance at the time of chronic myeloid leukemia (#CML) diagnosis/1

[YuMengge @yu_mengge]

@yuefeng_1 @Nature @LeonidasPlatan1 @TheDoctorIsVin @rosslevinemd @YaruiDiao @caoyuan3qiu Great work! May I ask one question: is RUNX1; t(9;22) actually CML blast crisis? Are those patients treated as CML?

[John Joson Ng @JohnJosonNg]

Our lab PI A/Prof. Ong Sin Tiong presented our lab's recent findings in CML in this year's #FCS2022 Frontiers of Cancer Science 2022, an annual cancer-focused conference held in Singapore.

[Enrico Petretto @Enrico_Petretto]

Happy to share our new paper on using 𝗠𝗼𝗴𝗿𝗶𝗳𝘆® for #drugdiscovery & #DrugRepurposing in 𝗹𝗲𝘂𝗸𝗮𝗲𝗺𝗶𝗮 𝗱𝗶𝗳𝗳𝗲𝗿𝗲𝗻𝘁𝗶𝗮𝘁𝗶𝗼𝗻 𝘁𝗵𝗲𝗿𝗮𝗽𝘆 for other subtypes of #leukemia or #cancer
with @OwenRackham @imouyang @EleniChristod16
https://t.co/yFUN31tOoA

[John Joson Ng @JohnJosonNg]

Our lab recently elucidated a RUNX1 mutation-associated gene expression signature in blast crisis CML. https://t.co/7ZijTypui7

[flowMSKCC @FlowMskcc]

Happy #flowpostit Monday! Curious how to tackle #tandemdyes to obtain the most optimal conditions for your flow experiment? look no further 👇

@WIBRFlow #flowcytometry #flowedu #flowcyto

[Jessie Ling Ai, Wong @JessieWongLA]

One of the few papers coming out from OST lab 🎊

[YuMengge @yu_mengge]

@syliu0125 Congrats!!!

[YuMengge @yu_mengge]

Congrats!!! Check the all-must-read CML study👉An integrative model of pathway convergence in genetically heterogeneous blast crisis chronic myeloid leukemia | Blood | American Society of Hematology https://t.co/JwQhysA6BB

[YuMengge @yu_mengge]

My favorite part of an expert talk is the first introduction slide. Always fascinating to hear how those with decades' experience describe the fundamental of their science in one or two sentences.

[YuMengge @yu_mengge]

When a bioinformatician tells me THIS algorithm identified a cluster that was missed by THAT and therefore THIS is better, me: so the cluster exists or not?